Neovasc to Submit Full PMA Application for Neovasc Reducer in 2019

Posted in Biotech

November 01, 2019 • 2 min read

Neovasc, Inc. (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it intends to submit a full Premarket Approval application ...

CareDx Reports Third Quarter 2019 Results

Posted in Biotech

October 31, 2019 • 2 min read

​CareDx, Inc. (NASDAQ: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers...

Tonix Pharmaceuticals Announces 1-for-10 Reverse Stock Split

Posted in Biotech

October 31, 2019 • 2 min read

​Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today that it will effect a 1-for-10 reverse stock split of its outstanding common stock....